Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Advertisement
Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. (ALXN) Stock Overview

Explore Alexion Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ALXN●NASDAQ
HealthcareBiotechnology
$182.50
$0.00(0.00%)
U.S. Market opens in 16h 42m
Advertisement

Alexion Pharmaceuticals, Inc. (ALXN)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio66.27
EPS (TTM)$3.08
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$178.90
3 Months$277.94
1 Year Target$417.62

ALXN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alexion Pharmaceuticals, Inc. (ALXN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $417.62.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 66.27 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
77.53%
All-Time (Max) Change
4913.74%

Contact Information

http://www.alexion.com
14752302596
121 Seaport Blvd, Boston, MA, 02210

Company Facts

38,370 Employees
IPO DateFeb 1, 1996
CountryUS

Frequently Asked Questions